BioWorld MedTech

Dec. 24, 2013

First patient receives fully implantable heart from French-based Carmat

PARIS – A 75-year old Frenchman was alert and joking with doctors the day after receiving a fully implantable bioprosthetic heart in a 10-hour operation at the Georges Pompidou European Hospital (Paris) on Dec. 18. Read More

FINANCINGS ROUNDUP: CSA Medical closes $16M Series C funding round

Intact starts enrollment for TOBA-BTK pilot study

Report cites inconsistencies in reviews of device applications

DEALS ROUNDUP: PTS acquires A1CNow and expands product portfolio

HIT ROUNDUP: CareCloud Charts meets ONC's Complete EHR 2014 criteria

RESTRUCTURING ROUNDUP: NuVasive Manufacturing to expand workforce by more than 25% in '14

People in the News:

Product Briefs:

Keeping you up to date with recent developments in Cardiology

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...